Home/Filings/4/0001140361-23-025988
4//SEC Filing

Tyagarajan N. V. 4

Accession 0001140361-23-025988

CIK 0001398659other

Filed

May 21, 8:00 PM ET

Accepted

May 22, 4:12 PM ET

Size

14.7 KB

Accession

0001140361-23-025988

Insider Transaction Report

Form 4
Period: 2023-05-18
Tyagarajan N. V.
Chief Operating Officer
Transactions
  • Exercise/Conversion

    Common Shares

    2023-05-18$19.35/sh+50,000$967,500855,509 total
  • Sale

    Common Shares

    2023-05-19$38.49/sh50,000$1,924,305805,509 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2023-05-1850,00050,000 total
    Exercise: $19.35Exp: 2023-05-30Common Shares (50,000 underlying)
  • Sale

    Common Shares

    2023-05-18$37.95/sh50,000$1,897,300805,509 total
  • Exercise/Conversion

    Common Shares

    2023-05-19$19.35/sh+50,000$967,500855,509 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2023-05-1950,0000 total
    Exercise: $19.35Exp: 2023-05-30Common Shares (50,000 underlying)
Holdings
  • Common Shares

    (indirect: By Trust)
    10,000
Footnotes (5)
  • [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022.
  • [F2]The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $37.69 to $38.222. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F3]The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $38.07 to $38.98. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F4]These shares are held in trust for the benefit of the reporting person's immediate family members. The reporting person's spouse is one of the trustees of the trust. The reporting person disclaims beneficial ownership of the reported securities held by the trust except to the extent of his pecuniary interest therein.
  • [F5]The option vested 50% on January 10, 2016 and the remainder on January 10, 2018.

Documents

1 file

Issuer

Genpact LTD

CIK 0001398659

Entity typeother

Related Parties

1
  • filerCIK 0001408239

Filing Metadata

Form type
4
Filed
May 21, 8:00 PM ET
Accepted
May 22, 4:12 PM ET
Size
14.7 KB